Life Science Today

Big compensation, mild mergers, a Kite in an updraft, and tightening the biotech belt

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Ginkgo
Eagle + Acacia
Gilead
Taysha/Orchard/Silverback

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

$2 billion in capital raises mostly by companies that start with the letter A.
 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
2seventy Bio
Ascendis
Apellis
Argenx

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Case closed on patents, Alzheimer’s data, generic approvals, and expanded approvals.  

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Alexion + Chugai
Biogen
Viatris
AbbVie

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Gilead
AstraZeneca + Merck + Myriad
DNAnexus


About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Who owns CRISPR, a collaboration, the classics, and more money for biotech.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Sanofi + Adagene
AbbVie + Syndesi
Atlas


About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

CRISPR works, the opioid epidemic makes amends (sort of), and the SPAC that wasn’t

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Intellia
Purdue Pharma
Amicus SPAC

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead
 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
Eli Lilly + Innovent Biologics
Agios
TC Biopharm
Blue Water Vaccines
Meihua


About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Dragons over unicorns, to CRISPR and beyond, spin-out-and-sell, and expanded approvals. 

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Arcellx
Intellia + Rewrite
Navitor + Janssen
ViiV


About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Bispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetime

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Genentech
Immunocore
Biogen
Eli Lilly
TenSixteen


About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Psychedelic SPACs, eczema frenzy, bio-outs without the biobucks, back on track, and the mega-deal that wasn’t

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Eleusis
Abbvie/Pfizer/Leo
UCB + Zogenix
Kura
GSK - Unilever

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.